Use of L-carnitine for the treatment of cardiovascular diseases

Details for Australian Patent Application No. 2004229256 (hide)

Owner Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.

Inventors Koverech, Aleardo

Agent Lord and Company

Pub. Number AU-A-2004229256

PCT Pub. Number WO2004/091602

Priority RM2003 A 000178 17.04.03 IT

Filing date 3 March 2004

Wipo publication date 28 October 2004

International Classifications

A61K 031/205

A61P 009/10 Drugs for disorders of the cardiovascular system

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/091602 Priority application(s): WO2004/091602

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229264-Follicle-stimulating hormone releasing agent

2004229253-Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles